Testing effectiveness (Phase 2)Active Not RecruitingNCT05565378
What this trial is testing
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 351